$MDT 2025 F/Y GUIDANCE 🔸 Sees ADJ EPS $5.44 to $5.50, saw $5.42 to $5.50, EST $5.45 🔸 Sees organic revenue +4.75% to +5%, saw +4.5% to +5% RESULTS: Q2 🔸 Revenue $8.40B, +5.2% y/y, EST $8.27B 🔸 Cardiovascular revenue $3.10B, +6.1% y/y, EST $3.06B 🔸 Medical Surgical revenue $2.13B, -0.7% y/y, EST $2.14B 🔸 Neuroscience revenue $2.45B, +7.1% y/y, EST $2.4B 🔸 Diabetes revenue $686M, +12% y/y, EST $662.3M